why choose us

First received: May 17, 2023

Clinical Trial: Metformin for Fibromyalgia Symptoms (INFORM Trial)

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Fibromyalgia Syndrome

Study Type: INTERVENTIONAL


Official Title: Metformin as a Novel, Mechanistic Treatment of Fibromyalgia; a Proof of Concept RCT

Brief Summary: The main purpose of the project is to evaluate the safety and efficacy of low dose metformin for improving symptoms associated with fibromyalgia syndrome (FMS) via modulating neuroinflammatory pathways.The investigators hypothesize that FMS patients in the low-dose metformin conditions will show greater improvement in FMS symptoms than those who are in the placebo group.Further, the investigators hypothesize that metformin will increase phosphorylated AMPK in peripheral immune cells of FMS patients and will…

Read more